Records containing: Migraine
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2026-02-04Localizing Functional Brain Cortices and Epileptogenic Zones With High Frequency Brain Signals
-
CLINICAL_TRIALS study record update · 2026-02-04Efficacy of Desvenlafaxine in the Preventive Treatment of Frequent Migraines -- Multicenter, Prospective, Randomized, Controlled Study
-
CLINICAL_TRIALS study record update · 2026-02-04Transcendence Research: Holistic Education For Colonized Countries Primarily English Speaking
-
CLINICAL_TRIALS study record update · 2026-01-30Biofeedback EMG Alternative Therapy for Chronic Low Back Pain and Chronic Cancer Pain (BEAT-Pain): A Pilot Efficacy Study
-
CLINICAL_TRIALS study record update · 2026-01-29Multicenter, Randomized, Double-blind, Placebo-controlled, Dose-ranging Phase II Trial of PRT-064040 Nasal Spray for the Acute Treatment of Migraine
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2026-01-28A Randomized, Double-blind, Single-dose, Placebo-controlled Study to Assess the Efficacy and Safety of AXS-07 (Meloxicam and Rizatriptan) for the Acute Treatment of Migraine in Adults
-
CLINICAL_TRIALS study record update · 2026-01-27Evaluating an App-Based Treatment for Migraine: The Health enSuite Migraine Study
-
CLINICAL_TRIALS study record update · 2026-01-22A Phase 2, Randomised, Multicentre, Parallel-Group Treatment, Double-Blind Study to Investigate the Safety and Efficacy of Subcutaneous MEDI0618 in the Reduction of Migraine Headache Days Compared to Placebo in Adult Participants With Episodic Migraine
-
CLINICAL_TRIALS study record update · 2026-01-22Comparing Patient-Reported Outcomes Between Rimegepant and Triptan Users With Migraine in the United States
-
CLINICAL_TRIALS study record update · 2026-01-22Diet-Based Treatment for Migraine Relief
-
CLINICAL_TRIALS study record update · 2026-01-22Evaluating the Effectiveness of Magnesium in Addition to Prochlorperazine for the Treatment of Migraines in the Emergency Department
-
CLINICAL_TRIALS study record update · 2026-01-22A Prospective, Registry-based, Observational Study to Assess Maternal, Fetal and Infant Outcomes Following Exposure to Rimegepant: The Migraine Observational Nurtec Pregnancy Registry (MONITOR)
-
CLINICAL_TRIALS study record update · 2026-01-21STudio Osservazionale Sull'Efficacia, Sicurezza e tollerabilità di Atogepant in Pazienti Real Life Affetti da Emicrania in Italia (Studio STAR)
-
CLINICAL_TRIALS study record update · 2026-01-21Effectiveness and Tolerability of Rimegepant as Acute Migraine Treatment: a Prospective, Multicentric, Cohort Study (GAINER)
-
CLINICAL_TRIALS study record update · 2026-01-21Comparative Efficacy of Flunarizine and Propanolol in Pediatric Migraine Using the PedMIDAS Measuring Tool.
-
CLINICAL_TRIALS study record update · 2026-01-21Central Sensitization and Migraine Disability Following Greater Occipital Nerve Pulsed Radiofrequency: A Prospective Observational Study
-
CLINICAL_TRIALS study record update · 2026-01-21Effectiveness and Tolerability of Lasmiditan as Acute Migraine Treatment: a Prospective, Multicentric, Cohort Study
-
CLINICAL_TRIALS study record update · 2026-01-21RimegepAnt effectIvenesS and tolErability as Migraine Preventive Treatment: a Prospective, Multicentric, Cohort Study (RAISE)
-
CLINICAL_TRIALS study record update · 2026-01-21The Effectiveness of Eptinezumab During a Migraine Attack (the BE-FREE Study)
-
CLINICAL_TRIALS study record update · 2026-01-20A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Efficacy and Safety of Erenumab in Children (6 to < 12 Years) and Adolescents (12 to < 18 Years) With Chronic Migraine (OASIS PEDIATRIC [CM])
-
CLINICAL_TRIALS study record update · 2026-01-20Post-marketing Surveillance Study to Evaluate the Safety and Effectiveness of Atogepant for the Prevention of Migraine in Korean Adult Patients
-
CLINICAL_TRIALS study record update · 2026-01-16Clinical Study of Myofascial Trigger Points(MTrPs) Injection in the Treatment of Chronic Musculoskeletal Pain(CMP), Chronic Migraine and Cervicogenic Headache
-
CLINICAL_TRIALS study record update · 2026-01-15A Prospective Study on the Effects of Percutaneous Patent Foramen Ovale Closure on Multimodal Brain Function, Cognition, and Emotion in Patients With Migraine and Patent Foramen Ovale
-
CLINICAL_TRIALS study record update · 2026-01-15China HeadAche DIsorders RegiStry
-
CLINICAL_TRIALS study record update · 2026-01-14A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Rimegepant for Migraine Prevention in Chinese Participants